Readers, in particular those in Scotland, may have read about the recent opening of a consultation to decriminalise sex work in Scotland. This Bill, Prostitution Law Reform (Scotland) Bill, is the first stage of an attempt to pass this legislation through the Scottish Parliament. Currently, in Scotland, the issue of sex working is covered by […]
Category: screening
Web-App Review: Petals
Ground breaking-anonymity features, and well-presented information, but needs to follow through. Petals is an online web application, developed by Coventry University, which aims to provide information and assistance to those who wish to know more about, or who are at risk of, FGM. Using the site is fairly straightforward. Accessed through the Petals homepage, it […]
Peer Reviewers Wanted
The Journal is seeking new peer reviewers. This would involve occasional work reviewing submitted papers for acceptance and advising on any final fine-tuning which needs to take place. This is done online, and reviewers can claim CPD using this work. If you would like further information, please contact info.jfprhc@bmj.com. […]
Hues and Cries: Colour Changing Condoms and Chlamydia Vaccines
Journal readers may be interested in the paper by Stary et al in last month’s edition of Science magazine, which reports on early trials of a mucosal, killed vaccine against Chlamydia. Chlamydia remains one of the most common sexually transmitted infections in the UK, and creates a significant disease burden with the associated risk of […]
Good Vibes: The FPA’s Novel Funding Strategy
The UK Sexual Health charity The Family Planning Association (FPA) is eighty-five years old this year, but its decision to broaden its funding opportunities by opening up an online shop specialising in sex toys proves that age is no barrier to experimentation. Set up in 1930, the FPA originally provided clinical services to the people […]
ESC 14th Congress in Basel
The 14th Congress and 2nd Global Conference of the European Society of Contraception and Reproductive Health will be held in Basel from 4th – 7th May 2016. The First announcement invites abstracts to be submitted by 15th November for presentations, free communications and posters The UK has many members and always has a significant presence […]
ellaOne® (ulipristal acetate) training roadshows
HRA Pharma UK has announced that, now that ellaOne® is available in UK Pharmacy without prescription, it will be launching a comprehensive training programme to support the introduction into pharmacy. Part of this programme includes seven interactive workshops which will take place at venues across the UK. These workshops will provide a summary of information […]
European Commission confirms EC access
The European Commission, in a historic ruling, has confirmed the authorisation of the emergency contraceptive, ellaOne® (ulipristal acetate, 30mg), to be accessible direct from pharmacies without the need for a prescription from a doctor. This is the first ever decision of its type regarding any oral contraceptive product applicable to all EU member states, according […]
The Future Is Here
Most of us, as healthcare professionals, would consider access to the internet to be an essential part of our work, whether this is for communicating with each other or keeping up to date with our field. For patients, the benefits of access to the internet are many. Being able to contact peer-support and information about […]
EMA recommends availability of ellaOne® emergency contraceptive without prescription
Change in status to facilitate access for women across Europe The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change in classification status from prescription to non-prescription for the emergency contraceptive ellaOne® (ulipristal acetate). This means that the medicine could be obtained without a prescription in the European Union […]